World Bank’s “Investing in Health”: The cost of antimicrobial resistance is too high to ignore
Enis Baris, sector manager of the World Bank’s health, nutrition, and population practice in Europe and Central Asia, discusses findings from a new World Bank report on antimicrobial resistance and its costs, writing, “All we need is a political commitment at the highest level for an additional annual investment of $9 billion into human and animal health. … [I]t is imperative that we do invest and invest now. And only then that we all, health care providers and patients alike, could safeguard the very essence of health care with humanism and compassion” (9/21).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.